Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / May 17, 2024 / RedChip Companies will air interviews with Calidi Biotherapeutics Inc. (NYSE American:CLDI) and Unusual Machines Inc. (NYSE American:UMAC) on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, May 18, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
佛羅里達州奧蘭多/ACCESSWIRE/2024年5月17日/RedChip Companies將在RedChip上播出對Calidi Biotherapeutics Inc.（紐約證券交易所美國股票代碼：CLDI）和不尋常機器公司（紐約證券交易所美國股票代碼：UMAC）的採訪 小股票，大資金 該節目是彭博電視臺贊助的節目，將於美國東部時間5月18日星期六晚上7點（美國東部時間）。據估計，彭博電視在美國有7,300萬個家庭可以觀看。
Access the interviews in their entirety at:
訪問訪談的全部內容，請訪問：
Calidi Biotherapeutics:
Calidi 生物療法：
Unusual Machines:
不尋常的機器：
In an exclusive interview, Allan Camaisa, Chief Executive Officer of Calidi Biotherapeutics, appears on the RedChip Small Stocks, Big Money show on Bloomberg TV to provide a corporate update. Calidi Biotherapeutics presents a compelling opportunity as a clinical-stage biotech at the forefront of oncolytic virotherapy (OV), a promising multi-billion-dollar area in cancer treatment. Calidi is pioneering the development of both systemic and localized OVs, leveraging engineered viruses to target and destroy cancer cells while arming the immune system for a comprehensive attack on tumors. Calidi's cell-based technologies uniquely protect OVs from immune system elimination, ensuring higher efficacy and opening the tumor microenvironment to treatment. This approach has shown promising efficacy in initial studies, while their breakthrough IV-based technology and direct tumor administration methods differentiate them within the oncology field.
Calidi Biotherapeutics首席執行官艾倫·卡邁薩在接受獨家採訪時出現在RedChip上 小股票，大資金 在彭博電視上播出以提供公司最新情況。作爲處於溶瘤病毒療法（OV）前沿的臨床階段生物技術公司，Calidi Biotherapeutics提供了一個絕佳的機會，溶瘤病毒療法是癌症治療領域前景廣闊的數十億美元領域。Calidi正在開創全身性和局部OV的開發，利用工程病毒靶向和摧毀癌細胞，同時武裝免疫系統，對腫瘤進行全面攻擊。Calidi的基於細胞的技術可獨特地保護OV免受免疫系統消除，從而確保更高的療效併爲治療開放腫瘤微環境。這種方法在初步研究中顯示出令人鼓舞的療效，而其基於靜脈注射的突破性技術和直接腫瘤給藥方法使它們在腫瘤學領域脫穎而出。
Allan Evans, CEO of Unusual Machines, appears on the RedChip Small Stocks, Big Money show on Bloomberg TV to provide a corporate update. Unusual Machines is gathering great teams, revenue generating customers, valuable IP, and high-quality brands, growing both organically and through strategic acquisitions within the highly fragmented drone industry. The Company is focused on investing in the development or acquisition of FPV products and services that serve a broad set of industries including consumer, public safety, and drone delivery. The Company's Fat Shark and Rotor Riot subsidiaries are setting the standard for FPV immersive experiences and are expected to continue to corner the consumer FPV market as Unusual Machines expands into new enterprise verticals over the next 24 months. As Unusual Machines capitalizes on the wealth of opportunities in the rapidly evolving drone market it is well positioned for long-term success.
《稀有機器》首席執行官艾倫·埃文斯出現在RedChip上 小股票，大資金 在彭博電視上播出以提供公司最新情況。Unsumal Machines正在聚集優秀的團隊、創收的客戶、寶貴的知識產權和高質量的品牌，在高度分散的無人機行業中實現有機增長和通過戰略收購實現增長。該公司專注於投資開發或收購FPV產品和服務，這些產品和服務適用於消費者、公共安全和無人機交付等廣泛行業。該公司的Fat Shark和Rotor Riot子公司正在爲FPV沉浸式體驗設定標準，隨着Unsouse Machines在未來24個月內向新的企業垂直領域擴展，預計將繼續壟斷消費類FPV市場。由於Unsour Machines充分利用了快速發展的無人機市場中的豐富機會，因此它完全有能力取得長期成功。
About Calidi Biotherapeutics
關於 Calidi Biotherapeut
Calidi Biotherapeutics (NYSE American:CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi's novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi's clinical stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Calidi's preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit .
Calidi Biotherapeutics（紐約證券交易所美國股票代碼：CLDI）是一家臨床階段的免疫腫瘤學公司，其專有技術旨在武裝免疫系統以對抗癌症。Calidi的新型幹細胞平台正在利用能夠攜帶有效載荷的溶瘤病毒的強效異體幹細胞，用於多種腫瘤適應症，包括高級神經膠質瘤和實體瘤。Calidi的臨床階段現成通用細胞遞送平台旨在保護、放大和增強溶瘤病毒，從而提高療效並提高患者安全性。Calidi的臨床前現成包膜病毒療法旨在靶向播散性實體瘤。這種雙重方法有可能治療甚至預防轉移性疾病。Calidi Biotherapeutics總部位於加利福尼亞州聖地亞哥。欲了解更多信息，請訪問。
About Unusual Machines
關於不尋常的機器
Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot e-commerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar US drone industry and the global defense business. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032.
Unsumer Machines製造和銷售多元化品牌組合中的無人機部件和無人機，其中包括面向無人機飛行員的FPV（第一人稱視角）超低延遲視頻護目鏡領域的領導者Fat Shark。該公司還通過精選的Rotor Riot電子商務商店直接向消費者零售小型雜技FPV無人機和設備。隨着監管環境的變化，Unsumal Machines尋求成爲快速增長的數十億美元美國無人機行業和全球國防業務的主要一級零部件供應商。根據Fact.mr的數據，全球無人機配件市場目前的價值爲175億美元，到2032年將突破1150億美元。
For more information visit Unusual Machines at
欲了解更多信息，請訪問不尋常的機器
About RedChip Companies
關於紅籌公司
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 32 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
RedChip Companies是一家5000公司，是一家國際投資者關係、媒體和研究公司，專注於微型股和小盤股公司。32年來，RedChip爲其客戶提供了具體、可衡量的業績。我們的時事通訊， 小股票，大資金， 每週向60,000名投資者在線交付。RedChip爲微型股和小盤股公司開發了業內最全面的服務平台。這些服務包括：股票研究的全球分銷網絡；美國主要城市的零售和機構路演；向股票經紀商、RIA、機構和家族辦公室進行境外營銷；產生數百萬獨特投資者觀點的數字媒體投資者關係平台；投資者網絡研討會和群組電話；電視節目， 小股票，大資金，每週在美國彭博社播出；本地和全國市場的電視廣告；企業和產品視頻；網站設計；以及傳統的投資者關係服務，包括新聞稿撰寫、投資者演示文稿的編寫、季度電話會議腳本撰寫、戰略諮詢、籌集資金等。
To learn more about RedChip's products and services, please visit:
要了解有關RedChip產品和服務的更多信息，請訪問：
"Discovering Tomorrow's Blue Chips Today"
“今天發現明天的藍籌股”
Follow RedChip on LinkedIn:
在領英上關注 RedChip：
Follow RedChip on Facebook:
在臉書上關注 RedChip：
Follow RedChip on Instagram:
在 Instagram 上關注 RedChip
Follow RedChip on Twitter:
在推特上關注 RedChip：
Follow RedChip on YouTube:
在 YouTube 上關注 RedChip
Follow RedChip on Rumble:
在 Rumble 上關注 RedChip：
Subscribe to our Mailing List:
訂閱我們的郵件列表：
Contact:
聯繫人：
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com
戴夫·金特里
RedChip Companies
1-407-644-4256
info@redchip.com
SOURCE: RedChip
來源：RedChip
譯文內容由第三人軟體翻譯。